Heidi M Ferguson (Heidi Ferguson)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Molecular Dynamics Simulations

Human Immunodeficiency Virus

Top Venues

Molecular pharmaceutics

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

James K Forder, Veerabhadraiah Palakollu, Sudeep Adhikari, Marco A Blanco, Mehabaw Getahun Derebe, Heidi M Ferguson, Suman A Luthra, Erik V Munsell, Christopher J Roberts
Electrostatically Mediated Attractive Self-Interactions and Reversible Self-Association of Fc-Fusion Proteins. Molecular pharmaceutics 21 (3) (2024)
James K Forder, Veerabhadraiah Palakollu, Sudeep Adhikari, Marco A Blanco, Mehabaw Getahun Derebe, Heidi M Ferguson, Suman A Luthra, Erik V Munsell, Christopher J Roberts
Electrostatically Mediated Attractive Self-Interactions and Reversible Self-Association of Fc-Fusion Proteins. Molecular pharmaceutics (2024)
James K Forder, Veerabhadraiah Palakollu, Sudeep Adhikari, Marco A Blanco, Mehabaw Getahun Derebe, Heidi M Ferguson, Suman A Luthra, Erik V Munsell, Christopher J Roberts
Electrostatically Mediated Attractive Self-Interactions and Reversible Self-Association of Fc-Fusion Proteins. Molecular pharmaceutics 21 (3) (2024)
Samanthi A Perera, Johnny E Kopinja, Yanhong Ma, Eric S Muise, Jason Laskey, Kalyan Chakravarthy, Yiping Chen, Long Cui, Jeremy P Presland, Manjiri Sathe, Sarah Javaid, Ellen C Minnihan, Heidi M Ferguson, Jennifer Piesvaux, Bo-Sheng Pan, Shuxia Zhao, Sharad K Sharma, Hyun Chong Woo, Vincenzo Pucci, Ian Knemeyer, Saso Cemerski, Jared Cumming, B Wesley Trotter, Archie Tse, Anuradha Khilnani, Sheila Ranganath, Brian J Long, David Jonathan Bennett, George H Addona
STimulator of INterferon Genes Agonism Accelerates Anti-tumor Activity in Poorly Immunogenic Tumors. Molecular cancer therapeutics (2021)
Luke Schenck, Christopher Boyce, Derek Frank, Sampada Koranne, Heidi M Ferguson, Neil Strotman
Hierarchical Particle Approach for Co-Precipitated Amorphous Solid Dispersions for Use in Preclinical In Vivo Studies. Pharmaceutics 13 (7) (2021)